Autonomix Medical Inc. logo

Autonomix Medical Inc.

AMIX | NASDAQ
Chart Builder DCF Calculator
$4.05
-$0.16 (-3.80%)
At close: Sep 21, 2026, 4:00 PM ET
$4.06
+$0.01 (+0.27%)
Pre-market: Sep 22, 2026, 9:15 AM ET

Company Profile

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Key Executives

Name Position
Bradley Hauser Chief Executive Officer & President
Landy Toth Co-Founder & Chief Technology Officer
Trent N. Smith Chief Financial Officer
David A. Robins Co-Founder & Independent Director
Jennifer Cook Chief Business Officer
Lori H. Bisson Executive Vice Chairman
Robert Schwartz Co-Founder & Chief Medical Officer
Walter V. Klemp Executive Chairman

Latest SEC Filings

Date Type Title
Sep 04, 2026 PRE 14A Filing
Sep 04, 2026 S-3 Filing
Aug 26, 2026 8-K Current Report
Aug 13, 2026 10-Q Quarterly Report
Aug 04, 2026 EFFECT Filing
Jul 31, 2026 424B5 Filing
Jul 28, 2026 S-3 Filing
Jul 28, 2026 8-K Current Report
Jul 15, 2026 8-K Current Report
Jul 10, 2026 8-K Current Report
View All SEC Filings
Autonomix Medical Inc.
Autonomix Medical Inc. logo
Country United States
IPO Date Jan 28, 2024
Industry Medical - Devices
Sector Healthcare
Employees 10
CEO Bradley A. Hauser

Contact Details

21 Waterway Avenue The Woodlands, Texas 77380 United States

Stock Details

Ticker Symbol AMIX
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001617867
CUSIP Number 05330T304
ISIN Number US05330T3041
SIC Code 3841

© 2026 bestshares.com. All rights reserved.